| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +20% |
| 3Y CAGR | +34% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +115% |
| 3Y CAGR | +57% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,345.20 +19.60 (0.84%) | 17,671.58 | 26.06 | 5.24 | ||
PfizerPFIZER | ₹3,624.70 -63.10 (1.71%) | 16,867.42 | 22.94 | 4.01 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,319.50 -45.00 (0.71%) | 15,918.38 | 93.84 | 18.24 | ||
Natco PharmaNATCOPHARM | ₹788.75 +6.35 (0.81%) | 15,350.14 | 13.41 | 1.46 |